Acute retinal necrosis epidemiology and demographics

Jump to: navigation, search

Acute retinal necrosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acute retinal necrosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acute retinal necrosis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acute retinal necrosis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acute retinal necrosis epidemiology and demographics

CDC on Acute retinal necrosis epidemiology and demographics

Acute retinal necrosis epidemiology and demographics in the news

Blogs on Acute retinal necrosis epidemiology and demographics

Directions to Hospitals Treating Acute retinal necrosis

Risk calculators and risk factors for Acute retinal necrosis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Luke Rusowicz-Orazem, B.S.

Overview

The estimated incidence of acute retinal necrosis (ARN) is approximately 6.3 per 100,000 individuals. ARN that has developed from Herpes simplex virus 1 or Varicella-zoster virus is most common among patients older than 50 years, while the incidence of HSV-2 caused ARN is highest in children and young adults between age 9 and 22 years. There is no racial or gender predisposition to acute retinal necrosis.

Epidemiology and Demographics

Incidence

  • The estimated incidence of ARN is approximately 6.3 per 100,000 individuals.
  • Worldwide, the increase in immunocompromised and aged populations in most countries has been correlated with an increase in the incidence of acute retinal necrosis.[1]
  • There is evidence that this incidence is underestimated due to biases in case adjudication and under-reporting of data.[2][3][4][5][6]

Age

Gender

There is no gender predisposition to acute retinal necrosis.

Race

There is no racial predisposition to acute retinal necrosis.

References

  1. Cochrane TF, Silvestri G, McDowell C, Foot B, McAvoy CE (2012). "Acute retinal necrosis in the United Kingdom: results of a prospective surveillance study". Eye (Lond). 26 (3): 370–7, quiz 378. doi:10.1038/eye.2011.338. PMC 3298997. PMID 22281865.
  2. Muthiah MN, Michaelides M, Child CS, Mitchell SM (2007). "Acute retinal necrosis: a national population-based study to assess the incidence, methods of diagnosis, treatment strategies and outcomes in the UK". Br J Ophthalmol. 91 (11): 1452–5. doi:10.1136/bjo.2007.114884. PMC 2095441. PMID 17504853.
  3. Usui Y, Goto H (2008). "Overview and diagnosis of acute retinal necrosis syndrome". Semin Ophthalmol. 23 (4): 275–83. doi:10.1080/08820530802111325. PMID 18584564.
  4. Kezuka T, Atherton SS (2007). "Acute retinal necrosis". Chem Immunol Allergy. 92: 244–53. doi:10.1159/000099275. PMID 17264500.
  5. Bonfioli AA, Eller AW (2005). "Acute retinal necrosis". Semin Ophthalmol. 20 (3): 155–60. doi:10.1080/08820530500232027. PMID 16282149.
  6. Chun HL, Missotten T, Salzmann J, Lightman SL (2007). "Acute Retinal Necrosis: Features, Management, and Outcomes". Opthalmology. 114: 756–762. Unknown parameter |Issue= ignored (|issue= suggested) (help)
  7. Brydak-Godowska J, Borkowski P, Szczepanik S, Moneta-Wielgoś J, Kęcik D (2014). "Clinical manifestation of self-limiting acute retinal necrosis". Med. Sci. Monit. 20: 2088–96. doi:10.12659/MSM.890469. PMC 4226315. PMID 25356955.

Linked-in.jpg